chr11-61770274-TGA-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_001127392.3(MYRF):c.492_493delGA(p.Glu164fs) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 31)
Consequence
MYRF
NM_001127392.3 frameshift
NM_001127392.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.91
Genes affected
MYRF (HGNC:1181): (myelin regulatory factor) This gene encodes a transcription factor that is required for central nervous system myelination and may regulate oligodendrocyte differentiation. It is thought to act by increasing the expression of genes that effect myelin production but may also directly promote myelin gene expression. Loss of a similar gene in mouse models results in severe demyelination. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 11-61770274-TGA-T is Pathogenic according to our data. Variant chr11-61770274-TGA-T is described in ClinVar as [Pathogenic]. Clinvar id is 2633042.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYRF | NM_001127392.3 | c.492_493delGA | p.Glu164fs | frameshift_variant | 5/27 | ENST00000278836.10 | NP_001120864.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYRF | ENST00000278836.10 | c.492_493delGA | p.Glu164fs | frameshift_variant | 5/27 | 1 | NM_001127392.3 | ENSP00000278836.4 | ||
MYRF | ENST00000265460.9 | c.465_466delGA | p.Glu155fs | frameshift_variant | 5/26 | 1 | ENSP00000265460.5 | |||
MYRF | ENST00000675319.1 | c.105-1223_105-1222delGA | intron_variant | ENSP00000502795.1 | ||||||
TMEM258 | ENST00000535042.1 | n.649-1503_649-1502delTC | intron_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
MYRF-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | May 17, 2023 | The MYRF c.492_493delGA variant is predicted to result in a frameshift and premature protein termination (p.Glu164Aspfs*63). To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Frameshift variants in MYRF are expected to be pathogenic. This variant is interpreted as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.